CDC issues updated Hepatitis A immunization recommendations for United States population
Health officials issue new recommendations for hepatitis A vaccination in the United States
The CDC has published updated recommendations for Hepatitis A immunization in the United States population.
New guidelines update who should get vaccinated against hepatitis A to better prevent infections across the United States.
Hepatitis A outbreak cases reported across 26 states in observational data
Health officials report hepatitis A outbreak cases across 26 states
An observational report describes hepatitis A outbreak cases reported from 26 states.
Hepatitis A cases are spreading across 26 states as public health officials track the outbreak.
Hepatitis A outbreak reported in the United States, details on scope and response not provided
Hepatitis A outbreak reported in the United States, details remain limited
A report describes a Hepatitis A outbreak in the United States.
Health authorities have announced a Hepatitis A outbreak is occurring in the United States, though specific details about locations or cause…
Report describes hepatitis A outbreak-related deaths in the United States
Report examines hepatitis A outbreak deaths in the United States
A report describes deaths related to hepatitis A outbreaks in the United States.
A new report describes deaths related to hepatitis A outbreaks in the United States, though key details about the study remain unavailable.
Surveillance report tracks drinking water-associated hepatitis A outbreaks from 1971 to 2017
U.S. tracked drinking water hepatitis A outbreaks for decades, report shows
A surveillance report from the Waterborne Disease and Outbreak Surveillance System tracked drinking water-associated hepatitis A outbreaks i…
A public health report tracks U.S. drinking water hepatitis A outbreaks from 1971 to 2017, serving as a record of incidents reported to the …
Hepatitis A infection reports increased 294% in the United States during 2016-2018
Hepatitis A infection reports increased sharply in the United States over recent years
An observational study in the United States found a 294% increase in hepatitis A infection reports during 2016-2018 compared with 2013-2015.
Reports of hepatitis A infections in the United States more than tripled between 2013 and 2018, rising by 294% in just three years.
Molecular testing used during hepatitis A outbreak investigation in Los Angeles County
How do health officials track a hepatitis A outbreak?
An outbreak investigation report describes the use of molecular testing during a hepatitis A outbreak in Los Angeles County, California.
Public health officials in Los Angeles County used molecular testing to track a hepatitis A outbreak and link cases together.
Field report notes increased hepatitis A virus concentrations in Los Angeles County wastewater during outbreak
Hepatitis A virus levels rose in Los Angeles wastewater during an outbreak
An observational field report from Los Angeles County, California, documented a significant increase in hepatitis A virus concentrations in …
Hepatitis A virus levels rose sharply in Los Angeles wastewater during a recent outbreak, confirming the virus was circulating more in the c…
Research across Hepatitis
Related studies from across the Hepatitis family.
Evaluating the Impact of Digital Health Interventions on Chronic Disease Self-Care Outcomes
Digital health tools show mixed results for managing chronic diseases
Digital tools show promise for heart failure monitoring but lack consistent evidence for improving medication adherence or general diabetes …
New data shows that while digital tools like apps can help heart failure patients monitor their health, they may not improve medication habi…
Epigallocatechin-3-gallate shows positive therapeutic effects on various digestive system diseases in animal models
Green tea compound shows potential for several digestive diseases
This meta-analysis of 63 preclinical studies involving 738 animals indicates that Epigallocatechin-3-gallate (EGCG) has a positive therapeut…
A review of animal studies suggests a green tea compound could help treat various cancers and digestive conditions.
HLA-B*57:01-guided abacavir prescribing is the clearest preventive paradigm from HLA associations
HLA genes shape HIV and hepatitis vaccine responses and drug reactions
This narrative review examines HLA polymorphisms in HIV, hepatitis C, and hepatitis B. The clearest preventive paradigm is HLA-B*57:01-guide…
A review finds that HLA genes strongly influence how people respond to HIV and hepatitis vaccines and how they react to certain medications.
PEG-IFN plus novel agents may boost functional cure in chronic hepatitis B
Combination therapies may improve functional cure rates for chronic hepatitis B
This narrative review examines combining pegylated interferon-α with novel immunotherapies (antigen-reduction strategies, therapeutic vaccin…
A review suggests combining pegylated interferon with new immunotherapies could help achieve functional cure in chronic hepatitis B patients…
Chronic HCV infection drives T cell dysfunction, regulatory T cell accumulation, and metabolic defects that persist after viral clearance
Immune defects in hepatitis C may last after the virus is gone
This narrative review examines immune mechanisms in patients with chronic hepatitis C virus infection. The authors describe how prolonged an…
A review explains how chronic hepatitis C causes lasting immune changes that persist even after the virus is cleared, suggesting new treatme…
One in six blood donors in Cameroon carries Plasmodium infection, meta-analysis finds
1 in 6 blood donors in Cameroon carries malaria parasite
A systematic review and meta-analysis of 18 studies (~12,500 donations) found a 16.6% pooled prevalence of Plasmodium spp. in Cameroonian bl…
A review of 18 studies finds 16.6% of blood donations in Cameroon contain Plasmodium, the malaria parasite.
Review of antiviral and immunotherapeutic strategies for chronic hepatitis B
New antiviral strategies show promise for chronic hepatitis B infection
This narrative review synthesizes evidence on antiviral and immunotherapeutic strategies for chronic hepatitis B. The authors highlight func…
A review of new treatments suggests combination therapies may offer future value for managing chronic hepatitis B, cirrhosis, and liver canc…
Meta-analysis identifies genetic variants linked to HBV susceptibility and HCC risk
Genetic Keys Unlock Why Some Get Liver Cancer From Hepatitis B
This meta-analysis of East Asian cohorts examined genetic variants associated with hepatitis B virus infection and hepatocellular carcinoma …
New research shows specific gene changes help explain why some people get Hepatitis B while others stay healthy.
Systematic review and meta-analysis of biopsy-guided versus clinically guided withdrawal in autoimmune hepatitis
Biopsy-guided withdrawal shows no benefit over clinical guidance for autoimmune hepatitis
This systematic review and meta-analysis evaluated relapse rates after treatment withdrawal in patients with autoimmune hepatitis.
A meta-analysis of 518 patients found that biopsy-guided withdrawal did not lower relapse rates compared to clinically guided withdrawal in …
HEV 239 vaccine induces durable humoral and cellular immunity in Bangladeshi women
Hepatitis E vaccine shows durable immunity in women
This longitudinal cohort study in 1480 women aged 16-39 years in Bangladesh found that HEV 239 (Hecolin) vaccination led to significantly hi…
A hepatitis E vaccine kept women protected for up to 3 years, with stronger immune memory than a comparison group.
Pegylated interferon alpha associated with HBsAg clearance in postpartum women with chronic HBV infection
New treatment clears hepatitis B in 3 out of 10 women after childbirth
This prospective cohort study evaluated 263 postpartum women with chronic hepatitis B virus infection and baseline HBsAg levels ≤3000 IU/mL.
A new treatment clears hepatitis B markers in nearly 30% of women after childbirth, offering fresh hope for a functional cure during a uniqu…
Hepatic steatosis prevalence and impact in autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis
Fatty liver makes autoimmune hepatitis and PBC worse, but not PSC
This systematic review and meta-analysis of 19,898 patients with autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing c…
A large review found fatty liver is common in autoimmune liver diseases and makes outcomes worse for some patients, but not others.
Questions about Hepatitis A
What details are available about the recent Hepatitis A outbreak in the United States?
Recent data shows a sharp rise in Hepatitis A cases across the U.S., with outbreaks linked to contaminated food, water, and specific geographic areas like Los Angeles County.
Full answer →What role did molecular testing play in the Los Angeles County Hepatitis A outbreak?
Molecular testing identified the specific strain of the virus in Los Angeles County, confirming the outbreak was caused by a single source and allowing officials to trace the spread to wastewater contamination.
Full answer →What are the new Hepatitis A immunization recommendations for the United States?
New recommendations focus on vaccinating adults at risk, including those who use drugs, are homeless, or have chronic liver disease, due to a major shift in how the virus spreads.
Full answer →